Getting regular checkups and colon cancer screening is the best way to prevent colorectal cancer. The US Preventive Services Task Force and the American Cancer Society both recommend that people ...
About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.